Diabetologia ( IF 8.4 ) Pub Date : 2024-12-10 , DOI: 10.1007/s00125-024-06308-z Othmar Moser, Dessi P. Zaharieva, Peter Adolfsson, Tadej Battelino, Richard M. Bracken, Bruce A. Buckingham, Thomas Danne, Elizabeth A. Davis, Klemen Dovč, Gregory P. Forlenza, Pieter Gillard, Sabine E. Hofer, Roman Hovorka, Peter G. Jacobs, Julia K. Mader, Chantal Mathieu, Kirsten Nørgaard, Nick S. Oliver, David N. O’Neal, John Pemberton, Rémi Rabasa-Lhoret, Jennifer L. Sherr, Harald Sourij, Martin Tauschmann, Jane E. Yardley, Michael C. Riddell
Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type 1 diabetes to achieve the recommended glucose target ranges. PA provide additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information and develop a position statement on the topic. This joint European Association for the Study of Diabetes (EASD)/International Society for Pediatric and Adolescent Diabetes (ISPAD) position statement reviews current evidence on AID systems and provides detailed clinical practice points for managing PA in children, adolescents and adults with type 1 diabetes using AID technology. It discusses each commercially available AID system individually and provides guidance on their use in PA. Additionally, it addresses different glucose responses to PA and provides stratified therapy options to maintain glucose levels within the target ranges for these age groups.
Graphical Abstract
中文翻译:
在 1 型糖尿病患者的身体活动和锻炼中使用自动胰岛素输送:欧洲糖尿病研究协会 (EASD) 和国际儿科和青少年糖尿病学会 (ISPAD) 的立场声明
定期的身体活动和锻炼 (PA) 是 1 型糖尿病患者糖尿病护理的基石。近年来,自动胰岛素输送 (AID) 系统的可用性提高了 1 型糖尿病患者达到推荐血糖目标范围的能力。PA 提供额外的健康益处,但会导致血糖波动,这对当前的 AID 系统提出了挑战。虽然越来越多的临床试验和综述正在不同的 AID 系统和 PA 上发表,但此时整理这些信息并就该主题制定立场声明似乎是谨慎的。这份欧洲糖尿病研究协会 (EASD)/国际儿科和青少年糖尿病学会 (ISPAD) 联合立场声明回顾了 AID 系统的当前证据,并提供了使用 AID 技术管理儿童、青少年和成人 1 型糖尿病 PA 的详细临床实践要点。它单独讨论了每个市售的 AID 系统,并提供了它们在 PA 中的使用指导。此外,它解决了对 PA 的不同葡萄糖反应,并提供分层治疗方案,以将葡萄糖水平维持在这些年龄组的目标范围内。